A smiling researcher wearing a white lab coat stands beside a laboratory workbench, with a microscope, equipment and teal storage cabinets in the background.

Sanders-Brown director’s drug candidate advances to Alzheimer’s clinical trial

For nearly two decades Linda Van Eldik, Ph.D., director of UK’s Sanders-Brown Center on Aging, has worked toward a goal: developing a drug that could help protect the brain from the damaging inflammation associated with Alzheimer’s disease. Now, a new grant from the National Institute on Aging will help her and a team of collaborators take the next step — testing the drug candidate in people with mild cognitive impairment or early Alzheimer’s disease.